SFU
Stonehage Fleming (UK) Portfolio holdings
AUM
$220M
This Quarter Return
+2.5%
1 Year Return
+0.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$236M
AUM Growth
+$236M
(-4.2%)
Cap. Flow
+$7.18M
Cap. Flow
% of AUM
3.04%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
354
New
88
Increased
46
Reduced
75
Closed
51
Top Buys
| 1 |
ProShares Short S&P500
SH
|
$6.22M |
| 2 |
Oracle
ORCL
|
$3.55M |
| 3 |
Genuine Parts
GPC
|
$3.39M |
| 4 |
OUTR
OUTERWALL INC
OUTR
|
$3.38M |
| 5 |
WESCO International
WCC
|
$3.27M |
Top Sells
| 1 |
Intel
INTC
|
$5.87M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
$5.48M |
| 3 |
SPLS
Staples Inc
SPLS
|
$5.39M |
| 4 |
AbbVie
ABBV
|
$3.99M |
| 5 |
Gilead Sciences
GILD
|
$3.58M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Industrials | 17.82% |
| 3 | Healthcare | 14.68% |
| 4 | Energy | 6.84% |
| 5 | Consumer Discretionary | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.9B
| $3.19M | 1.35% |
18,090
-3,700
| -17% | -$653K |
|
27
Parker-Hannifin
PH
$94.8B
| $3.19M | 1.35% |
+26,600
| New | +$3.19M |
|
28
Charles River Laboratories
CRL
$7.99B
| $3.17M | 1.34% |
+52,600
| New | +$3.17M |
|
29
Intuit
INTU
$187B
| $3.16M | 1.34% |
+40,700
| New | +$3.16M |
|
30
Omnicom Group
OMC
$15B
| $3.16M | 1.34% |
+43,500
| New | +$3.16M |
|
|
ARRS
31
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $3.15M | 1.33% |
+111,800
| New | +$3.15M |
|
|
BRCM
32
DELISTED
BROADCOM CORP CL-A
BRCM
| $3.14M | 1.33% |
+99,900
| New | +$3.14M |
|
|
LLL
33
DELISTED
L3 Technologies, Inc.
LLL
| $3.12M | 1.32% |
26,400
+1,300
| +5% | +$154K |
|
34
Cardinal Health
CAH
$36B
| $3.11M | 1.32% |
+44,500
| New | +$3.11M |
|
35
Macy's
M
$4.42B
| $3.11M | 1.32% |
52,500
+1,500
| +3% | +$89K |
|
36
Nu Skin
NUS
$596M
| $3.1M | 1.31% |
37,400
-9,000
| -19% | -$746K |
|
37
GE Aerospace
GE
$293B
| $2.76M | 1.17% |
106,611
-8,100
| -7% | -$209K |
|
38
Bristol-Myers Squibb
BMY
$96.7B
| $2.41M | 1.02% |
46,450
| – | – |
|
|
DNY
39
DELISTED
DONNELLEY R R & SONS CO
DNY
| $2.28M | 0.97% |
127,500
-53,600
| -30% | -$959K |
|
40
Deluxe
DLX
$852M
| $2.26M | 0.96% |
43,099
-54,700
| -56% | -$2.87M |
|
41
RTX Corp
RTX
$212B
| $2.21M | 0.93% |
18,875
| – | – |
|
|
42
AbbVie
ABBV
$374B
| $2.11M | 0.89% |
41,000
-77,700
| -65% | -$3.99M |
|
43
Western Union
WU
$2.82B
| $2.08M | 0.88% |
127,050
-118,600
| -48% | -$1.94M |
|
44
Altria Group
MO
$112B
| $2.05M | 0.87% |
54,747
| – | – |
|
45
Brady Corp
BRC
$3.68B
| $1.98M | 0.84% |
+73,000
| New | +$1.98M |
|
46
Flowserve
FLS
$6.99B
| $1.97M | 0.83% |
25,110
| – | – |
|
47
Pfizer
PFE
$141B
| $1.94M | 0.82% |
60,686
-5,230
| -8% | -$168K |
|
48
Analog Devices
ADI
$120B
| $1.84M | 0.78% |
34,600
| – | – |
|
49
Merck
MRK
$210B
| $1.76M | 0.74% |
30,920
| – | – |
|
50
BHP
BHP
$142B
| $1.58M | 0.67% |
23,450
+5,000
| +27% | +$338K |
|